Dataset Information


Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology Group correlative study on E4494.

ABSTRACT: PURPOSE:To prospectively investigate the prognostic significance of p21 and p53 expression in diffuse large B-cell lymphoma in the context of the U.S. Intergroup trial comparing conventional cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy to rituximab-CHOP (R-CHOP) induction, with or without maintenance rituximab. EXPERIMENTAL DESIGN:Immunohistochemical staining of 197 paraffin-embedded biopsy specimens was scored by an independent panel of experts. RESULTS:The cyclin-dependent kinase inhibitor, p21, was expressed in 55% of cases examined. In a multivariable analysis adjusting for International Prognostic Index score and BCL2 status, p21 expression was a significant, independent, favorable predictive factor for failure-free survival (relative risk, 0.3; P = 0.001) and overall survival (relative risk, 0.3; P = 0.003) for patients treated with R-CHOP. Expression of p21 was not predictive of outcome for CHOP-treated patients. Only p21-positive cases benefited from the addition of rituximab to CHOP. Among p21-positive patients, treatment with R-CHOP was associated with a higher failure-free survival rate at 5 years compared with CHOP (61% versus 24%; P = 0.01). In contrast, no significant differences were detected in failure-free survival according to treatment arm for p21-negative patients. Expression of p53, alone or in combination with p21, did not predict for outcome in univariable or multivariable analyses. CONCLUSIONS:In this study, p21 protein expression emerged as an important independent predictor of a favorable clinical outcome when rituximab was added to CHOP therapy. These data suggest that rituximab-related effects on lymphoma survival pathways may be functionally linked to p21 activity.


PROVIDER: S-EPMC2865202 | BioStudies | 2010-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6366826 | BioStudies
1000-01-01 | S-EPMC2951853 | BioStudies
2011-01-01 | S-EPMC7394278 | BioStudies
2008-01-01 | S-EPMC2675107 | BioStudies
2019-01-01 | S-EPMC6639223 | BioStudies
2009-08-15 | E-MEXP-2305 | ArrayExpress
1000-01-01 | S-EPMC5078098 | BioStudies
2014-01-01 | S-EPMC4107050 | BioStudies
2020-01-01 | S-EPMC7154735 | BioStudies
2018-01-01 | S-EPMC5757680 | BioStudies